WARREN, N.J., May 3, 2021
/PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK), the makers
of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%)
today revealed new data that uncovers a painful truth: for people
with osteoarthritis (OA), mornings can be the most difficult part
of the day. The study, conducted by OnePoll on behalf of Voltaren,
found that among 1,000 people with OA surveyed, 67% of Americans
reported their joint pain makes it difficult for them to get out of
bed in the morning based on their activities from the previous day.
This May, national Arthritis Awareness Month, Voltaren is
empowering those with joint pain and stiffness to feel the joy of
movement and help them take on their day.
After a night of inactivity, aches and pains can be at their
worst first thing in the morning. In fact, a painful morning can
throw off your entire day, the study shows. Nearly three-quarters
of respondents reported that feeling OA pain when they wake up
ruins their entire morning, and more than three-quarters of those
surveyed reported OA negatively affects them three or more days a
week. While 35% described themselves as early birds prior to being
diagnosed with OA, only one-quarter are still early risers since
learning they have OA.
Joint pain can also impact the livelihoods of people with OA.
For the millions of Americans who wake up for work with the sun, OA
poses real challenges. The study found that 56% of employed
Americans living with OA have shown up late to work because of
their pain, and more than half have even had to change their jobs
because of it.
"Our research has helped us understand the authentic experience
of people with OA, and shows just how difficult mornings can be,
especially those who are up and moving very early," said
Rishi Mulgund, Pain Portfolio Brand
Director at GSK Consumer Healthcare, "As a brand, we want to
support people with OA in the mornings, with a topical option that
is an alternative to pain relief pills."
Voltaren, the #1 doctor-recommended topical pain relief brand,
is the first full prescription strength, clinically-proven
nonsteroidal anti-inflammatory (NSAID) gel available over the
counter. An alternative to pills, Voltaren is applied directly to
the site of pain, delivering powerful arthritis pain relief. It is
indicated for the treatment of arthritis pain in the hand, wrist,
elbow, foot, ankle or knee. To date, millions of patients around
the world have relied on Voltaren as a powerful, well-tolerated and
convenient therapeutic alternative for treating arthritis pain.
During Arthritis Awareness Month, Voltaren is proud to feature
the stories of real people living with osteoarthritis who wake up
and power through early mornings. Stay tuned throughout the month
of May for Voltaren's three-part content series, which will air on
local and national broadcast and online news outlets, featuring
people with OA who refuse to let pain hold them back, and pain
relief experts who will offer their advice on how people everywhere
can experience the joy of less painful mornings.
Additionally, as part of a multi-year partnership with the
Arthritis Foundation to support scientific research, advocacy and
community connections for people with arthritis, Voltaren is
matching donations made to the Arthritis Foundation (up to
$100,000) throughout Arthritis
Awareness Month and lending its support to the Arthritis
Foundation's annual Walk to Cure Arthritis events.
Voltaren Arthritis Pain Gel is available online and at most
major retailers nationwide. To learn more about Voltaren, visit
www.voltarengel.com.
About Voltaren Arthritis Pain Gel
An alternative to
pills, Voltaren Arthritis Pain Gel targets pain directly at the
source to deliver clinically-proven nonsteroidal anti-inflammatory
medicine for powerful arthritis pain relief with a proven safety
profile. For more information,
visit https://www.VoltarenGel.com/.
About osteoarthritis
Osteoarthritis (OA) is the most
common form of arthritis. OA occurs when the cartilage between
joints begins to break down and wear away, resulting in joint pain
and stiffness. OA occurs more frequently with age, and the pain can
gradually worsen over time. The most common symptoms associated
with OA include joint pain, stiffness, and decreased range of
motion.
GSK's commitment to pain relief
We are the world
leader in pain relief. With a portfolio of (systemic and topical)
products to relieve pain, our range brings comfort and ease to
millions. World-leading brands including Advil, Panadol and
Voltaren; and beloved local brands like Excedrin in the US and
Fenbid in China help people manage
their symptoms so they can enjoy life to the fullest.
Important safety information about Voltaren Arthritis
Pain
Before using the product, consumers should read the
Voltaren Arthritis Pain Gel Drug Facts Label.
* Methodological Notes
The GSK Voltaren Survey was
conducted by OnePoll (www.onepoll.us) throughout the month of
April 2021. The survey sampled a
random group of 1,000 employed Americans diagnosed with
osteoarthritis.
This random double-opt-in survey was conducted by OnePoll – a
market research company and corporate member of both the American
Association for Public Opinion Research (AAPOR) and the European
Society for Opinion and Marketing Research (ESOMAR) – and adheres
to the MRS code of conduct. For more information about OnePoll's
research in the media, navigate to their portfolio here.
About GSK Consumer Healthcare
GSK Consumer Healthcare
combines science and consumer insights to create innovative
world-class health care brands that consumers trust and experts
recommend for oral health, pain relief, respiratory and
wellness. For further information please visit
www.gsk.com.
Media
Inquiries:
|
|
|
|
|
|
|
|
GSK Consumer
Healthcare
|
Caitlin
Kormann
|
+1 617 448
0557
|
(Warren)
|
Edelman
|
Jessica
Moschella
|
+1 201 953
1547
|
(New York
City)
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/voltaren-arthritis-pain-gel-empowers-early-morning-risers-living-with-osteoarthritis-301282039.html
SOURCE GSK Consumer Healthcare